Literature DB >> 32980979

Return on Investment of a Breast Cancer Screening Program in Tanzania: Opportunity for Patient and Public Education.

Zoe Heisler1, Betsy Eastwood1, Julius Mwaiselage2, Crispin Kahesa2, Khadija Msami2, Amr S Soliman3.   

Abstract

Breast cancer is the second incident and second cause of cancer mortality among women in Tanzania due to late-stage presentation. The screening clinic at the Ocean Road Cancer Institute (ORCI) can help detect cases early and reduce cost of treatment. We calculated the return on investment (ROI) of the ORCI breast screening clinic. Screening and treatment data of all newly diagnosed breast cancer patients seen at ORCI during 2016-2018 were abstracted from the medical records. Also, data on time, resources, and cost of screening and treatment were obtained. The cost of treating screened patients was compared with cost of treating unscreened patients, and differences in cost of treatment were compared with cost of operating the screening program. Of the 730 total patients, 58 were screened prior to treatment, and 672 were not. There was no significant difference between stage at diagnosis and treatments received by screened and unscreened patients (79.3% late- stage vs 72.2% late-stage diagnosis, respectively (p = .531), or cost of treatment between the two groups (cost, in Tanzanian Shillings, for screened (2,167,155.14 or $954.27) vs unscreened (1,918,592.28 or $844.52), (p = .355). There was also no significant difference in cost of treatment between the screened and unscreened groups and a slightly negative ROI (- 0.05%) from implementing the program. The breast screening clinic in Tanzania has not yet proven its cost-effectiveness in reducing stage with screening. The likelihood that patients have utilized the clinic for treatment rather than early detection is a possible reason for the lack of cost-effectiveness. Future studies should focus on educational initiatives to encourage screening at early disease stage. Public education should increase awareness about the clinic for early detection. The experience of this program is ideal for dissemination to other low-income countries that are initiating cancer early detection and cancer education programs.
© 2020. American Association for Cancer Education.

Entities:  

Keywords:  Breast cancer; Patient education; Public education; Return on investment; Screening; Tanzania

Mesh:

Year:  2020        PMID: 32980979      PMCID: PMC7997813          DOI: 10.1007/s13187-020-01871-6

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   1.771


  15 in total

1.  Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.

Authors:  Alena N Skrundevskiy; Omar S Omar; Jungyoon Kim; Amr S Soliman; Theodore A Korolchuk; Fernando A Wilson
Journal:  Value Health Reg Issues       Date:  2018-04-04

2.  Cost-Effectiveness of Screening and Treatment for Cervical Cancer in Tanzania: Implications for other Sub-Saharan African Countries.

Authors:  Stephanie Nelson; Jungyoon Kim; Fernando A Wilson; Amr S Soliman; Twalib Ngoma; Crispin Kahesa; Julius Mwaiselage
Journal:  Value Health Reg Issues       Date:  2016-05-19

3.  Patient-mediated factors predicting early- and late-stage presentation of breast cancer in Egypt.

Authors:  Jaye M Stapleton; Patricia B Mullan; Subhojit Dey; Ahmed Hablas; Rabab Gaafar; Ibrahim A Seifeldin; Mousumi Banerjee; Amr S Soliman
Journal:  Psychooncology       Date:  2011-05       Impact factor: 3.894

4.  Clinical and epidemiologic profile of breast cancer in Tanzania.

Authors:  Ashley M Burson; Amr S Soliman; Twalib A Ngoma; Julius Mwaiselage; P Ogweyo; Mohab S Eissa; Subhojit Dey; Sofia D Merajver
Journal:  Breast Dis       Date:  2010

5.  Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.

Authors:  Quirine Lamberts Okonkwo; Gerrit Draisma; Arno der Kinderen; Martin L Brown; Harry J de Koning
Journal:  J Natl Cancer Inst       Date:  2008-09-09       Impact factor: 13.506

6.  Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service.

Authors:  Helen Blumen; Kathryn Fitch; Vincent Polkus
Journal:  Am Health Drug Benefits       Date:  2016-02

Review 7.  Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality.

Authors:  Lydia E Pace; Lawrence N Shulman
Journal:  Oncologist       Date:  2016-04-18

8.  The cost of breast cancer screening in the Medicare population.

Authors:  Cary P Gross; Jessica B Long; Joseph S Ross; Maysa M Abu-Khalaf; Rong Wang; Brigid K Killelea; Heather T Gold; Anees B Chagpar; Xiaomei Ma
Journal:  JAMA Intern Med       Date:  2013-02-11       Impact factor: 21.873

9.  Most women diagnosed with cervical cancer by a visual screening program in Tanzania completed treatment: evidence from a retrospective cohort study.

Authors:  Andrew C Gard; Amr S Soliman; Twalib Ngoma; Julius Mwaiselage; Crispin Kahesa; Robert M Chamberlain; Siobán D Harlow
Journal:  BMC Public Health       Date:  2014-09-03       Impact factor: 3.295

10.  Global patterns and trends in the breast cancer incidence and mortality according to sociodemographic indices: an observational study based on the global burden of diseases.

Authors:  Kaimin Hu; Peili Ding; Yinan Wu; Wei Tian; Tao Pan; Suzhan Zhang
Journal:  BMJ Open       Date:  2019-10-07       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.